BIO praised a Florida Senate committee for passing a bill that would require pharmacists to notify physicians when a biosimilar drug was substituted for a brand-name biologic. S.B. 732 has a five-year sunset clause like the law signed in Virginia last month. "Biosimilars are not generics. Even slight changes to a biologic drug can change its properties entirely. Unlike conventional generic medicines, biosimilars are not the same as the drugs they seek to substitute," the BIO statement said.

Full Story:
Drug Store News

Related Summaries